Symbax—the Zyprexa/Prozac Eli Lilly combo drug approved for depression

This drug was approved quite a long time ago for "bipolar-depression," and has now been approved for plain old garden variety depression, uh, make that "treatment resistant" garden-variety depression which seems to be about 70% of depression because, well, the treatment psychiatry routinely uses DON'T work. Nope antidepressants routinely don't work, so now they want... Continue Reading →

Eli Lilly and the Case for a Corporate Death Penalty — Bruce Levine

By Bruce Levine from Alternet. Unfortunately,  Eli Lilly is alone in its criminal behavior. This is standard practice in Big Pharma. AstraZeneca is currently behaving in digusting fashion regarding it's drug Seroquel and well GlaxoSmithKline has done all sorts of artful activity covering up its tracks around it's blockbuster drug Paxil. Also just today Doug... Continue Reading →

It’s the Cymbalta stupid

From OpEDNews the lastest criminal activity on Eli Lilly's part. I don't have any commentary. Martha Rosenberg does a fine job without my adding my two cents: Many are outraged that Eli Lilly gave nonprofits $3.9 million in grants last year for medical courses to "educate" doctors about the pain-and-fatigue ailment fibromyalgia--more than it spent... Continue Reading →

AstraZeneca makers of Seroquel want to “protect” us by withholding information about the dangers of the drug

This you've got to read!! From the St. Petersburg Times: AstraZeneca, maker of the blockbuster anti­psychotic Seroquel, is battling to keep information about the drug out of the public's view … for the public's own good. This month in Orlando, lawyers for the drugmaker will argue that unsealing company documents, including unpublished clinical trial data... Continue Reading →

Pushing drugs pharma style

From America Public Media Radio the program The Story: Shahram Ahari believes that the relationship between pharmaceutical companies and doctors can compromise the health of patients. Shahram knows what he's talking about: he was a drug rep with Eli Lilly, where he learned how to entice doctors with gifts, slanted statistics, and psychological profiles. He... Continue Reading →

Powered by WordPress.com.

Up ↑